Fig. 7From: Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)Proportion of responders on both the BPRS and GAF scales. Patients were considered “responders” if they showed an improvement of at least 20% of the BPRS total score and an improvement of at least 10 points on the GAFBack to article page